GeneralConnection.com ➔ Dictionary
Dictionary Search

immunogen

Synonyms

Noun

1. immunizing agent

2. antigen

Usage
With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset - Fierce Pharma
AbbVie's Immunogen buy delivers rare cancer drug approval - pharmaphorum
When on-target misses the mark: Lessons from HIV immunogens - Fred Hutchinson Cancer Center
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Camp - The Killeen Daily Herald
Immunogen-free CRISPR platform reveals metastatic drivers - CRISPR Medicine News
Immunogenic relationship mapping supports a minimal-set trivalent vaccine strategy for broad sarbecovirus protection - Nature
Kadcyla, Sarclisa ADC veteran John Lambert joins Defence board - Stock Titan
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice - Science | AAAS
IMGN Stock: ImmunoGen’s Acquisition and Final Market Status - Bitget
Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles - Nature
AbbVie seeks lift from 'guided missile' cancer drug with $10 bln ImmunoGen deal - Reuters
AbbVie to Acquire ImmunoGen With its Platinum-Resistant Ovarian Cancer Drug Elahere - Pharmaceutical Executive
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion - CNBC
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule - Fierce Pharma
Antibodies induced by antigen-containing liposomes as immunogens preferentially recognize their antigens present on lipid vesicles - Nature
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field - Fierce Pharma
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope - Nature
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on - Fierce Pharma
Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus - Nature
Protein engineering strategies for rational immunogen design - npj Vaccines - Nature
AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion - WSJ
AbbVie Buys ImmunoGen in $10B Deal, Gains Access to ADC for Ovarian Cancer - BioSpace
Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end - Fierce Biotech
Latham’s Antitrust Team Achieves Global Regulatory Approvals for AbbVie’s US$10.1 Billion Acquisition of ImmunoGen - Latham & Watkins LLP
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutations - Science | AAAS
AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion - statnews.com
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen - Nature
AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise - Genetic Engineering and Biotechnology News
AbbVie Sees Early ROI on $10B Immunogen Buy in Phase II Ovarian Cancer Win - BioSpace
Four decades in, ImmunoGen gets landmark green light in advanced ovarian cancer - Fierce Pharma
Engineered immunogen binding to alum adjuvant enhances humoral immunity - Nature
FDA grants accelerated approval for ImmunoGen’s ovarian cancer ADC - Pharmaceutical Technology
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout - BioPharma Dive
Germline-targeting immunogens guide bnAb development - Nature
After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype - Fierce Pharma
ImmunoGen Announces Conference Call to Discuss Its 2022 Operating Results - Business Wire
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors - Inside Precision Medicine
ImmunoGen Stock Soars 80% on AbbVie's $10 Billion Takeover - Barron's
AbbVie diversifies oncology portfolio with $10.1 bn ImmunoGen acquisition - Pharmaceutical Technology
ImmunoGen drug prolongs survival of women with advanced ovarian cancer - statnews.com
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy - Fierce Biotech
ImmunoGen (IMGN) Q2 Earnings and Sales Beat, Shares Down - Yahoo Finance
AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play - Medical Marketing and Media
AbbVie concludes acquisition of ImmunoGen for $10.1bn - Pharmaceutical Technology
AbbVie Treatment for Ovarian, Other Gynecological Cancers Approved by MHRA - BioPharm International
Mosaic HIV immunogens boost the breadth of vaccine immune responses - European AIDS Treatment Group
AbbVie ADC bolster with $10bn ImmunoGen bid - BioProcess Insider - BioProcess International
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes - Nature
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies - Nature
ImmunoGen reports positive top-line data from ovarian cancer therapy trial - Clinical Trials Arena
ImmunoGen’s commitment to Elahere pays off with $10.1B AbbVie takeout - biocentury.com
ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice - Nature
AbbVie to Acquire ImmunoGen in Deal Valued at $10.1 Billion - BioPharm International
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients - Clinical Trials Arena
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio - Investopedia
AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel - Bloomberg.com
ImmunoGen’s ADC Elahere wins FDA priority review for ovarian cancer - Pharmaceutical Technology
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope - Nature
Takeda collaborates with ImmunoGen for ELAHERE - Pharmaceutical Technology
Q&A: Mark Enyedy, ImmunoGen - Pharmaceutical Executive
AbbVie agrees $10.1bn deal to buy ImmunoGen - pharmaphorum
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies - Science | AAAS
ImmunoGen’s ADC misses endpoint in ovarian cancer phase 3 - Fierce Biotech
ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer - pharmaphorum
Federal Circuit Affirms ImmunoGen Patent Obviousness - ArentFox Schiff
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens - Nature
For ImmunoGen, persistence pays off as FDA clears ovarian cancer drug - BioPharma Dive
Immunogen wins FDA approval for targeted medicine to treat advanced ovarian cancer - statnews.com
ImmunoGen, Inc. Announces $200 Million Non-Dilutive Royalty Transaction - TPG Inc.
DNA-encoded immunogens: the next step forward in HIV vaccine research - BioTechniques
ImmunoGen, Takeda Partner to Commercialize ELAHERE in Japan - Contract Pharma
AbbVie Tries Its Hand at ADCs Again With $10.1B Immunogen Acquisition - MedCity News
ADC specialist ImmunoGen closing Massachusetts plant, cutting 20 jobs - Fierce Pharma
Anti-(idio)typical: a new immunogen to vaccinate against RSV - Fred Hutchinson Cancer Center
ImmunoGen Announces FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian Cancer - Business Wire
A Rapid Virus-Free Method for Producing Influenza HA Immunogen Needed for Preparation of Influenza Vaccine Potency Antisera Reagents - Wiley Online Library
AbbVie ends stay with the ADAM family, dropping MacroGenics-partnered ADC in light of early data - Fierce Biotech
Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles - Nature
Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products - PR Newswire
ImmunoGen commercial chief to withdraw before drug launch - Medical Marketing and Media
Rational engineering of minimally immunogenic nucleases for gene therapy - Nature
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines | npj Vaccines - Nature
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design - Nature
ImmunoGen Licenses Cancer Compounds to Sanofi - Genetic Engineering and Biotechnology News
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines | npj Vaccines - Nature
AbbVie strikes deal to acquire Waltham’s ImmunoGen for more than $10 billion - The Boston Globe
AbbVie Completes Deal to Acquire ImmunoGen With its Flagship ADC Elahere - Pharmaceutical Executive
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia - Nature
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win - Fierce Pharma
AbbVie Bolsters Oncology Portfolio with ImmunoGen's Flagship Ovarian Cancer Treatment ELAHERE - BioPharma APAC
Corporate Presentation for 41 st Annual JP Morgan Healthcare Conference - SEC.gov - SEC.gov
AbbVie to spend $10.1B to acquire ImmunoGen, 43-year-old Waltham biotech - The Business Journals
ImmunoGen’s ovarian cancer drug misses Phase III primary endpoint - Clinical Trials Arena
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy - Nature
Design of immunogens to present a tumor-specific cryptic epitope - Nature
Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes - Wiley Online Library
ImmunoGen Shares Plunge after Phase III Failure of Lead ADC in Ovarian Cancer - Genetic Engineering and Biotechnology News
FDA Approves New IV Tx for Cancers – Elahere - Anton Health
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM - Nature
Foreign Language Equivalents
Foreign Language Equivalents of 'immunogen'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
immmunogen,   imunogen,   immunogrn,   immunogenn,   mmunogen,   immnuogen,   immubogen,   immungoen,   imumnogen,   immnogen,   immumogen,   immunoogen,   immunogem,   immunofen,   immynogen,   imunogen,   immunogwn,   immunoegn,   inmunogen,   immmunogen,   im,unogen,   immungen,   i,munogen,   ommunogen,   immunogn,   immunogeb,   mimunogen,   immuogen,   immunohen,   imminogen,   immunnogen,   immuunogen,   immunogeen,   immunpgen,   immunoggen,   immunogne,   immunoen,   immuongen,   immunigen,   imnunogen,   ummunogen,   iimmunogen,   immunoge
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z